Drugs / hydroxyethyl starch
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02700607 Comparator | Jun 2016 → Mar 2017 | brain aneurysm | Konkuk University Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hydroxyethyl starch | “We hypothesized that administering balanced crystalloid (Group-C) or hydroxyethyl starch (HES) 130/0.4 (Group-HES) for IV fluid management would have a different impact on...” PMID 41250652 ↗ Nov 2025 |
| Known as | HES | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02700607 ↗ |